Prognostic markers in Breast cancer
Not Applicable
- Conditions
- Health Condition 1: null- Mastectomy specimen of breast cancer
- Registration Number
- CTRI/2014/03/004455
- Lead Sponsor
- FR MULLER MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
The patients with primary carcinoma of breast undergoing surgery in Father Muller Medical college.
Exclusion Criteria
•The patients whose specimens are fixed in formalin.
•Necrotic and highly desmoplastic tumors with scanty cellularity.
•Extensive in situ comedo component.
•Mucinous carcinomas.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the degree of correlation between immunocytochemistry (ICC) and immunohistochemistry (IHC) of ER, PR and HER-2/neu in Breast cancer.Timepoint: 2years
- Secondary Outcome Measures
Name Time Method to determine the role of scrape cytology in immunocytochemistryTimepoint: 2years